Idasanutlin, Ixazomib Citrate, and Dexamethasone in Treating Patients With Relapsed Multiple Myeloma

NCT02633059 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

33

Enrollment

OTHER

Sponsor class

Conditions

Loss of Chromosome 17p
Recurrent Plasma Cell Myeloma

Interventions

DRUG: Dexamethasone
DRUG: Idasanutlin
DRUG: Ixazomib Citrate
OTHER: Laboratory Biomarker Analysis
OTHER: Pharmacological Study

Sponsor

Mayo Clinic